A PHASE II TRIAL OF TAMOXIFEN AND BORTEZOMIB IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA

被引：0
|
作者：
Aregawi, Dawit [1 ]
Kreisl, Teri N. [2 ]
Innis, Ellen [3 ]
Fine, Howard A. [4 ]
机构：
[1] NCI, Neurooncol Branch, Bethesda, MD 20892 USA
[2] Columbia Univ, Neurol Inst, New York, NY USA
[3] Univ Maryland, Baltimore, MD 21201 USA
[4] NYU, Inst Canc, NYU Langone Med Ctr, New York, NY USA
来源：
NEURO-ONCOLOGY | 2014年 / 16卷
关键词：
D O I：
10.1093/neuonc/nou237.6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AT-06
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: Phase I/II study
    Stevens, GHJ
    Hercbergs, AA
    Goyal, LK
    Suh, JH
    Barnett, GH
    NEUROLOGY, 2002, 58 (07) : A15 - A15
  • [42] Phase I study of terameprocol in patients with recurrent high-grade glioma
    Grossman, Stuart A.
    Ye, Xiaobu
    Peereboom, David
    Rosenfeld, Myrna R.
    Mikkelsen, Tom
    Supko, Jeffrey G.
    Desideri, Serena
    NEURO-ONCOLOGY, 2012, 14 (04) : 511 - 517
  • [43] Phase II trial of temozolomide in patients with progressive low-grade glioma
    Quinn, JA
    Reardon, DA
    Friedman, AH
    Rich, JN
    Sampson, JH
    Provenzale, JM
    McLendon, RE
    Gururangan, S
    Bigner, DD
    Herndon, JE
    Avgeropoulos, N
    Finlay, J
    Tourt-Uhlig, S
    Affronti, ML
    Evans, B
    Stafford-Fox, V
    Zaknoen, S
    Friedman, HS
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (04) : 646 - 651
  • [44] Phase II trial of combination pembrolizumab, olaparib, and temozolomide for patients with recurrent glioma
    Schaff, Lauren
    Fortunato, John
    Grommes, Christian
    Gavrilovic, Igor T.
    Lin, Andrew
    Pentsova, Elena
    Miller, Alex
    Newton, Adam
    Gonzalez, Ashley
    Mellinghoff, Ingo K.
    Kaley, Thomas Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [45] PHASE II TRIAL OF PEMBROLIZUMAB IN RECURRENT AND RESIDUAL HIGH-GRADE MENINGIOMAS
    Brastianos, Priscilla
    Kim, Albert
    Giobbie-Hurder, Anita
    Lee, Eudocia Quant
    Wang, Nancy
    Eichler, April
    Chukwueke, Ugonma
    Forst, Deborah
    Arrillaga-Romany, Isabel
    Dietrich, Jorg
    Lou, Kevin
    Larson, Juliana
    Mora, Joana
    Nayyar, Naema
    Loeffler, Jay
    Oh, Kevin
    Shih, Helen
    Curry, William
    Cahill, Daniel
    Barker, Fred
    Gerstner, Elizabeth
    Santagata, Sandro
    NEURO-ONCOLOGY, 2021, 23 : 57 - 57
  • [46] A phase I trial of hypofractionated stereotactic radiation therapy with sunitinib in recurrent high grade glioma
    Wuthrick, E. J.
    Curran, W. J.
    Lin, A.
    Glass, J.
    Evans, J.
    Andrews, D.
    Axelrod, R.
    Murphy, H.
    Werner-Wasik, M.
    Dicker, A. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S205 - S205
  • [47] Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcoma
    Geoerger, Birgit
    Kieran, Mark W.
    Grupp, Stephan
    Perek, Danuta
    Clancy, Jill
    Krygowski, Mizue
    Ananthakrishnan, Revathi
    Boni, Joseph P.
    Berkenblit, Anna
    Spunt, Sheri L.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (02) : 253 - 262
  • [48] Phase II Trial of Oral Vinorelbine in Children with Progressive or Recurrent Unresectable Low-Grade Glioma
    Leblond, P.
    Bimbai, A. -M.
    Probst, A.
    Chastagner, P.
    DeCarli, E.
    Pagnier, A.
    Grill, J.
    Entz-Werle, N.
    Bourdeaut, F.
    Faure-Conter, C.
    Bertozzi, A. -I.
    Boulanger, T.
    Caron, S.
    Le Deley, M. -C.
    Andre, N.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S82 - S83
  • [49] Phase II trial of imatinib mesylate and hydroxyurea for adults with recurrent/progressive low-grade glioma
    Bota, D. A.
    Desjardins, A.
    Quinn, J. A.
    Rich, J. N.
    Vredenburgh, J. J.
    Sathornsumetee, S.
    Goli, K.
    Salvado, A.
    Friedman, H. S.
    Reardon, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [50] A Phase II Trial of Bendamustine, Bortezomib, and Rituximab in Patients with Previously Untreated Low Grade Lymphoma
    Flinn, Ian W.
    Ervin, Thomas J.
    Boccia, Ralph V.
    Flora, Douglas B.
    Cuevas, J. Daniel
    Thompson, Dana S.
    Shipley, Dianna L.
    Berdeja, Jesus G.
    BLOOD, 2015, 126 (23)
12345